Clinical Trial Update: Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

View source ↗

Summary

This clinical trial update describes an ongoing real-world study evaluating pembrolizumab or nivolumab in combination with brentuximab vedotin for relapsed/refr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• KEYTRUDA (PEMBROLIZUMAB)
• OPDIVO (nivolumab)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Primary Mediastinal B Cell Lymphoma | Status: RECRUITING